Press Releases
🇪🇺 EMA Page 5EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 49–60 of 121 articles
Brii Bio's Elebsiran Shows Durable Hepatitis B Control in APASL 2026 Cross-Study Analysis
Aetna Standardizes 88% of Prior Authorization Volume, Exceeds Industry Commitments for Healthcare Access
Guerbet's Lipiodol Ultra Fluid Achieves EU Regulatory Milestone for Vascular Embolization Procedures
RNA Therapy Clinical Trials Market Reaches $3.4 Billion as Personalized Medicine Drives Growth Through 2035
Oncotelic Therapeutics Updates Partnership Strategy for Cancer Drug Development Pipeline
CLINUVEL Receives EMA Approval for SCENESSE Phase III Vitiligo Trial Starting 2026
RenovoRx TAMP Therapy Platform Data Accepted for 2026 ASCO Presentation - Phase III TIGeR-PaC Trial Results
Genomics Services Market to Reach $24 Billion by 2033 as Precision Medicine Adoption Accelerates
Accenture Invests in Iridius to Accelerate AI Compliance Solutions for Life Sciences Companies
Pharmaceutical Company Reports Continued Growth Momentum in Q1 2026 Sales Results
Cumberland Pharmaceuticals Announces Strategic Integration with Apotex in Major Commercial Partnership Deal
Tilray Brands Positioned for Major U.S. Medical Cannabis Expansion Following Historic Rescheduling